Searched for: author%3A%22Lansink%2C+M.%22
(1 - 13 of 13)
document
Lansink, M. (author), Jong, M. (author), Bijsterbosch, M. (author), Bekkers, M. (author), Toet, K. (author), Havekes, L. (author), Emeis, J. (author), Kooistra, T. (author), Gaubius instituut TNO (author)
Several clinical studies have demonstrated an inverse relationship between circulating levels of estrogen and tissue-type plasminogen activator (t-PA). The present study was designed to test the hypothesis that estrogen lower plasma levels of t-PA by increasing its clearance from the bloodstream. 17α-Ethinyl estradiol (EE) treatment resulted in...
article 1999
document
Lansink, M. (author), Koolwijk, P. (author), van Hinsbergh, V. (author), Kooistra, T. (author), Gaubius Instituut TNO (author)
Angiogenesis, the formation of new capillary blood vessels, is a feature of a variety of pathological processes. To study the effects of a specific group of hormones (all ligands of the steroid/retinoid/thyroid hormone receptor superfamily) on the angiogenic process in humans, we have used a model system in which human microvascular endothelial...
article 1998
document
Quax, P.H.A. (author), Grimbergen, J.M. (author), Lansink, M. (author), Bakker, A.H.F. (author), Blatter, M.C. (author), Belin, D. (author), van Hinsbergh, V.W.M. (author), Verheijen, J.H. (author), Gaubius Instituut TNO (author)
Urokinase-type plasminogen activator (UPA), particularly when bound to its receptor (UPAR), is thought to play a major role in local proteolytic processes, thus facilitating cell migration as may occur during angiogenesis, neointima and atherosclerotic plaque formation, and tumor cell invasion. To facilitate understanding of the need and...
article 1998
document
van Kesteren, P.J.M. (author), Kooistra, T. (author), Lansink, M. (author), van Kamp, G.J. (author), Asscheman, H. (author), Gooren, L.J.G. (author), Emeis, J.J. (author), Vischer, U.M. (author), Stehouwer, C.D.A. (author), Gaubius Instituut TNO (author)
We studied thirteen male-to-female (M→F) and ten female-to-male (F→M) transsexuals who, for four months, received cross-sex treatment with, respectively, ethinylestradiol and cyproterone acetate, and with testosterone esters. We assessed the effects of treatment on plasma levels of tissue-type plasminogen activator (tPA), von Willebrand factor ...
article 1998
document
TNO Preventie en Gezondheid (author), Lansink, M. (author)
doctoral thesis 1998
document
Arts, J. (author), Herr, I. (author), Lansink, M. (author), Angel, P. (author), Kooistra, T. (author), TNO Preventie en Gezondheid (author)
Tissue-type plasminogen activator (t-PA) gene expression in human endothelial cells and HeLa cells is stimulated by the protein kinase C activator phorbol 12-myristate 13-acetate (PMA) at the level of transcription. To study the mechanism of transcriptional regulation, we have characterized a segment of the t-PA gene extending from -135 to +100...
article 1997
document
Kluft, C. (author), Lansink, M. (author), Gaubius Instituut TNO (author)
Combined oral contraceptives (COCs) have effects on a large number of haemostasis variables. We have summarised literature data on effects of COCs containing 30-35 μg ethinyl estradiol for the third generation of progestogens (PGs): desogestrel, gestodene and norgestimate. It is concluded that about 15 variables show a shift in distribution of...
article 1997
document
Lansink, M. (author), van Bennekum, A.M. (author), Blaner, W.S. (author), Kooistra, T. (author), TNO Preventie en Gezondheid (author)
Retinoic acid stimulates the expression of tissue-type plasminogen activator (t-PA) in vascular endothelial cells in vitro and enhances t-PA levels in plasma and tissues in vivo. Compared with the in vivo situation, high retinoic acid concentrations are required to induce optimally t-PA expression in vitro. These findings led us to study...
article 1997
document
Kooistra, T. (author), Lansink, M. (author), Emeis, J.J. (author), TNO Preventie en Gezondheid (author)
Chemicals/CAS: 4 [2 (5,6,7,8 tetrahydro 5,5,8,8 tetramethyl 2 naphthyl) 1 propenyl]benzoic acid, 71441-28-6; butyric acid, 107-92-6, 156-54-7, 461-55-2; cyclic AMP, 60-92-4; protein kinase C, 141436-78-4; retinoic acid, 302-79-4; tissue plasminogen activator, 105913-11-9; trichostatin A, 58880-19-6
article 1996
document
Lansink, M. (author), Blaner, W.S. (author), Kooistra, T. (author), Gaubius Instituut TNO (author)
Chemicals/CAS: cytochrome P450, 9035-51-2; retinoic acid, 302-79-4
article 1996
document
Kooistra, T. (author), Lansink, M. (author), van Kesteren, P. (author), Koolwijk, P. (author), Toet, K. (author), Peters, E. (author), Hegeman, R. (author), Emeis, J. (author), Stehouwer, C. (author), Gooren, L. (author), van Hinsbergh, V.W.M. (author), Gaubius Instituut TNO (author)
article 1996
document
Lansink, M. (author), Toet, K. (author), Emeis, J.J. (author), Kooistra, T. (author), Gaubius Laboratory TNO Preventie en Gezondheid (author)
We and others have previously shown that retinoids (vitamin A derivatives) regulate t-PA synthesis in human endothelial cells in vitro and in rats in vivo. Retinoids exert their effect on t-PA expression via specific nuclear receptors, retinoic acid receptors (RARs). of which several subtypes and isoforms exist. Using subtype-specific retinoids...
article 1996
document
Lansink, M. (author), Kooistra, T. (author), Gaubius Laboratory, Leiden, Netherlands Gaubius Laboratory TNO-PG, P.O. Box 2215, 2301 CE Leiden, Netherlands TNO Preventie en Gezondheid (author)
We previously showed the involvement of retinoic acid receptor α (RARα) in the induction of tissue-type plasminogen activator (t-PA) synthesis by RA in human umbilical vein endothelial cells (HUVECs). However, the rather slow onset of this induction of t-PA synthesis suggested an indirect role of RARα. Here, we show that the protein synthesis...
article 1996
Searched for: author%3A%22Lansink%2C+M.%22
(1 - 13 of 13)